Proinflammatory cytokine activation is linked to apoptotic mediator, soluble Fas level in patients with chronic heart failure

International Heart Journal

Volumn 53, Issue 3, 2012, Pages 182-186

  Kinugawa, Toru ^a   Kato, Masahiko ^b   Yamamoto, Kazuhiro ^b   Hisatome, Ichiro ^c   Nohara, Ryuji ^d  

^a Kinugawa Cardiology Clinic   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

^d Kitano Hospital   (Japan)

Author keywords

Cardiopulmonary exercise test; Heart failure; Proinflammatory cytokine; Soluble Fas

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; FAS ANTIGEN; GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; NORADRENALIN; SOLUBLE FAS ANTIGEN; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR 1; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; BICYCLE ERGOMETRY; BODY MASS; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; FEMALE; GAS ANALYSIS; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LUNG GAS EXCHANGE; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX RATIO;

AGED; ANTIGENS, CD95; APOPTOSIS; CHRONIC DISEASE; CYTOKINES; EXERCISE TEST; FAS LIGAND PROTEIN; FEMALE; GLYCOPROTEINS; HEART FAILURE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REFERENCE VALUES; STATISTICS AS TOPIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84863488049     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.53.182     Document Type: Article

References (30)

1. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-41.
2. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996; 27: 1201-6.
3. Mann DL. Recent insights into the role of tumor necrosis factor in the failing heart. Heart Fail Rev 2001; 6: 71-80. (Review)
4. Ferrari R, Bachetti T, Confortini R, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995; 92: 1479-86.
5. Aukrust P, Ueland T, Lien E, et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1999; 83: 376-82.
6. Kang PM, Izumo S. Apoptosis and heart failure: A critical review of the literature. Circ Res 2000; 86: 1107-13. (Review)
7. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233-43.
8. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169: 1747-56.
9. Suda T, Takahashi T, Goldstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-78.
10. Iio S, Hayashi N, Mita E, et al. Serum levels of soluble Fas antigen in chronic hepatitis C patients. J Hepatol 1998; 29: 517-23.
11. Okuyama M, Yamaguchi S, Nozaki N, Yamaoka M, Shirakabe M, Tomoike H. Serum levels of soluble form of Fas molecule in patients with congestive heart failure. Am J Cardiol 1997; 79: 1698-701.
12. Nishigaki K, Minatoguchi S, Seishima M, et al. Plasma Fas lig-and, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol 1997; 29: 1214-20.
13. Kawakami H, Shigematsu Y, Ohtsuka T, et al. Increased circulating soluble form of Fas in patients with dilated cardiomyopathy. Jpn Circ J 1998; 62: 873-6.
14. Tsutamoto T, Wada A, Maeda K, et al. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure. J Card Fail 2001; 7: 322-8.
15. Niessner A, Hohensinner PJ, Rychli K, et al. Prognostic value of apoptosis markers in advanced heart failure. Eur Heart J 2009; 30: 789-96.
16. Kinugawa T, Ogino K, Noguchi N, et al. Sympathetic nervous response relative to the adenosine triphosphate supply-demand imbalance during exercise is augmented in patients with heart failure. Chest 1998; 114: 1295-300.
17. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996; 335: 1182-9.
18. Bennett MR. Apoptosis in the cardiovascular system. Heart 2002; 87: 480-7. (Review)
19. Lanfear DE, Hasan R, Gupta RC, et al. Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure. J Transl Med 2009; 7: 67.
20. Adamopoulos S, Parissis J, Karatzas D, et al. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. J Am Coll Cardiol 2002; 39: 653-63.
21. Porapakkham P, Porapakkham P, Zimmet H, Billah B, Krum H. B-type natriutetic peptide-guided heart failure therapy: A meta-analysis. Arch Intern Med 2010; 170: 507-14.
22. Tanaka M, Ito H, Adachi S, et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994; 75: 426-33.
23. Wollert KC, Drexler H. The role of interleukin-6 in the failing heart. Heart Fail Rev 2001; 6: 95-103. (Review)
24. Choi C, Park JY, Lee J, et al. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. J Immunol 1999; 162: 1889-95.
25. Kubota T, Miyagishima M, Frye CS, et al. Overexpression of tumor necrosis factor-alpha activates both anti-and pro-apoptotic pathways in the myocardium. J Mol Cell Cardiol 2001; 33: 1331-44.
26. Seishima M, Takemura M, Saito K, et al. Highly sensitive ELISA for soluble Fas in serum: increased soluble Fas in the elderly. Clin Chem 1996; 42: 1911-4.
27. Kishimoto T, Akira S, Narazaki M, Toga T. Interleukin-6 family of cytokines and gp130. Blood 1995; 86: 1243-54. (Review)
28. Plenz G, Song ZF, Tjan TD, et al. Activation of the cardiac interleukin-6 system in advanced heart failure. Eur J Heart Fail 2001; 3: 415-21.
29. Anker SD, Clark AL, Kemp M, et al. Tumor necrosis factor and steroid metabolism in chronic heart failure: Possible relation to muscle wasting. J Am Coll Cardiol 1997; 30: 997-1001.
30. Aukrust P, Lien E, Kristoffersen AK, et al. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency-possible immunological and clinical consequences. Blood 1996; 87: 674-81.